Company Overview of ImmunoGenetix Therapeutics, Inc.
ImmunoGenetix Therapeutics, Inc., a biotechnology company, develops DNA immunotherapies for reducing the dependency on anti-HIV drug cocktails and diminishing the emergence of drug-resistant HIV strains. It offers GenePro (?4SHIVku2), a DNA therapeutic that incorporates a DNA construct to yield gene expression and non-infectious HIV protein production; and induce an antibody and cellular immune response in animal models, including non-human primates. ImmunoGenetix Therapeutics, Inc. was incorporated in 2001 and is based in Lenexa, Kansas.
8527 Bluejacket Street
Lenexa, KS 66214
Founded in 2001
Key Executives for ImmunoGenetix Therapeutics, Inc.
ImmunoGenetix Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|Traversa Therapeutics, Inc.||United States|
|Marketing Systems of America Inc.||United States|
|Pioneer Surgical Orthobiologics Inc.||United States|
|Icogenex Corporation||United States|
|Ovalis, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Greater Houston Partnership||United States|
Post a JobJobs
- Miami, FL | MedtronicPosted: Feb 01
- San Mateo, CA |Posted: Apr 05
- Kansas City, MO | SkillsniperPosted: Apr 14
- San Francisco, CA | Anacor PharmaceuticalsPosted: Feb 23
Sponsored Financial Commentaries
To contact ImmunoGenetix Therapeutics, Inc., please visit www.immunogenetix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.